At meeting held on 27 July 2018
The Board of Vanta Bioscience has approved to foray into clinical research business. The Board has approved the following -(1) Incorporation of a 100% subsidiary in the name of Vanta Clinical Research at Hyderabad; and
(2) Incorporation of a 51% step down subsidiary of the above mentioned company in the name of Vanta Research Solutions at Hyderabad.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
